The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Astellas Oncology; Bristol-Myers Squibb; Ipsen; Pfizer; Sanofi
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Ipsen; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Exelixis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Research Funding - Bayer (Inst); Roche (Inst)
The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as a biomarker of taxane resistance in castration-resistant prostate cancer.
 
Òscar Reig
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Sanofi
Travel, Accommodations, Expenses - Ipsen
 
Mercedes Marin
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Maria Mila
No Relationships to Disclose
 
Albert Font
Consulting or Advisory Role - Janssen; Roche; Sanofi
 
Montserrat Domenech
No Relationships to Disclose
 
Alejo Rodriguez Vida
Honoraria - Astellas Oncology; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; MSD Oncology; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Oncology; Bayer; Bristol-Myers Squibb; Janssen; MSD Oncology; Pfizer; Roche
Research Funding - MSD Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen; Novartis
 
Joan Carles
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Johnson & Johnson; MSD Oncology; Pfizer; Sanofi
Speakers' Bureau - Asofarma; Bayer; Johnson & Johnson
 
Cristina Suárez
No Relationships to Disclose
 
Aranzazu Gonzalez del Alba
Honoraria - Astellas Pharma; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; PFIZER; Sanofi
 
Natalia Jiménez
No Relationships to Disclose
 
Iván Victoria
Travel, Accommodations, Expenses - Bayer
 
Nuria Sala
No Relationships to Disclose
 
Maria Jose Ribal
No Relationships to Disclose
 
Sandra López
No Relationships to Disclose
 
Olatz Etxaniz
No Relationships to Disclose
 
Pablo Maroto
No Relationships to Disclose
 
Pedro L. Fernandez
Consulting or Advisory Role - Guidepoint Pharmacy
 
Aleix Prat
Honoraria - Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; NanoString Technologies (Inst); Novartis; Oncolytics; Roche
Research Funding - NanoString Technologies (Inst)
 
Begona Mellado
Consulting or Advisory Role - Astellas Oncology; Bristol-Myers Squibb; Ipsen; Janssen; Novartis; Pfizer; Roche; Sanofi
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Janssen; Pfizer